title: Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.
abstract: BACKGROUND
  Recently, remission criteria for schizophrenia have been proposed, based on low symptom severity of core symptoms (severity criterion), sustained over minimally 6 months (time criterion). Little is known, however, about the added value of the time criterion in addition to the cross-sectional severity criterion.
  
  
  METHODS
  In order to evaluate whether remission is a valid concept for daily clinical practice, the cumulative incidence of patients meeting remission criteria was evaluated in a large naturalistic prospective study of patients with schizophrenia or schizoaffective disorder in different treatment settings in Belgium. The impact of being in remission on global and daily functioning was evaluated.
  
  
  RESULTS
  Over time, nearly 1 out of 3 patients with a diagnosis of schizophrenia or schizoaffective disorder (29%) met criteria for remission at study endpoint. Patients in remission had better insight in their disorder, a higher level of global functioning and functioned better with respect to daily living tasks, both compared to patients never meeting remission criteria and to patients only meeting the severity criterion but not the time criterion. Of the patients not meeting remission criteria at baseline, 21% attained remission at study endpoint.
  
  
  CONCLUSIONS
  The remission severity and time criteria appear to combine into a valid concept for daily clinical practice and should be a target for treatment.
authors.affiliation: University Psychiatric Centre Catholic University Louvain, Leuvensesteenweg 517, 3070 Kortenberg, Belgium. marc.de.hert@uc-kortenberg.be
authors.forename: Marc
authors.initials: M
authors.lastname: De Hert
authors.forename: Ruud
authors.initials: R
authors.lastname: van Winkel
authors.forename: Martien
authors.initials: M
authors.lastname: Wampers
authors.forename: John
authors.initials: J
authors.lastname: Kane
authors.forename: Jim
authors.initials: J
authors.lastname: van Os
authors.forename: Joseph
authors.initials: J
authors.lastname: Peuskens
mesh_terms: D000328:Adult; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D011446:Prospective Studies; D011618:Psychotic Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D012074:Remission Induction; D012559:Schizophrenia / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome